Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  iC9-GD2-CD28-OX40-expressing T lymphocytes
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Genetically Modified T Lymphocytes in Treating Patients With Relapsed or Refractory High-Risk Neuroblastoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: H-31493, NCI-2013-02413, GRAIN, H-31493 GRAIN, NCT01822652
T Cell Receptor Gene Therapy in Treating Younger Patients with Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 35 and under
Trial IDs: 14-C-0059, NCI-2014-02506, P131369, NCT02107963
Start Over